H Stewart Parker's Net Worth
$557 Thousand
Who is H Stewart Parker?
H Stewart Parker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SANGAMO THERAPEUTICS, INC, IMPEL NEUROPHARMA INC, TARGETED GENETICS CORP /WA/, ONCOGENEX PHARMACEUTICALS, INC., CODEXIS, INC., and NEOSE TECHNOLOGIES INC.
SEC CIK
H Stewart Parker's CIK is 0001217456
Past Insider Trading and Trends
2021 was H Stewart Parker's most active year for acquiring shares with 10 total transactions. H Stewart Parker's most active month to acquire stocks was the month of April. 2021 was H Stewart Parker's most active year for disposing of shares, totalling 8 transactions. H Stewart Parker's most active month to dispose stocks was the month of March. 2011 saw H Stewart Parker paying a total of $30,275.10 for 3,000 shares, this is the most they've acquired in one year. In 2021 H Stewart Parker cashed out on 388,956 shares for a total of $521,959.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +39.94% | 25K |
—
|
—
| 87.6K |
Jun 4
| |||
Form 4
| +28.54% | 13.9K |
—
|
—
| 62.6K |
Jun 1
| |||
Form 4
| +11.44% | 5K |
$3.60 | $17,996.00 | 48.7K |
Jun 1
| |||
Form 4
| +40.06% | 12.5K |
—
|
—
| 43.7K |
Feb 25
| |||
Form 4
| +35.65% | 8.2K |
—
|
—
| 31.2K |
Feb 25
| |||
Form 4/A
| +76.92% | 10K |
—
|
—
| 23K |
May 18
| |||
Form 4
| +19.23% | 2.5K |
—
|
—
| 15.5K |
May 18
| |||
Form 4
| +30.00% | 3K |
$5.20 | $15,585.00 | 13K |
Mar 18
| |||
Form 4
| +33.33% | 2.5K |
—
|
—
| 10K |
Jun 10
| |||
Form 4
| +36.36% | 2K |
$9.00 | $18,001.60 | 7.5K |
Nov 14
| |||
Form 4
| +57.14% | 2K |
$13.52 | $27,040.00 | 5.5K |
Sep 7
| |||
Form 4
| +250.00% | 2.5K |
—
|
—
| 3.5K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL NEUROPHARMA INC (IMPL) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 18.03K |
$13.50 |
—
| 18.03K |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TARGETED GENETICS CORP /WA/ (ARMP) Snapshot price: $2.4
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +61.60% | 50K |
—
|
—
| 131.18K |
May 15
| |||
Form 4
| +160.38% | 50K |
—
|
—
| 81.17K |
May 17
| |||
Form 4
| +47.23% | 10K |
$1.99 | $19,927.60 | 31.18K |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
| No matching records found | |||||||||
ONCOGENEX PHARMACEUTICALS, INC. (ACHV) Snapshot price: $4.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 20
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
| +25.00% | 2.5K |
—
|
—
| 12.5K |
May 20
| |||
Form 4
| +33.33% | 2.5K |
—
|
—
| 10K |
May 20 - May 21
| |||
Form 4
| +50.00% | 2.5K |
—
|
—
| 7.5K |
Jun 5
| |||
Form 4
| +66.67% | 2K |
$10.64 | $21,280.00 | 5K |
May 23 - May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
∞
| 3K |
$10.09 | $30,275.10 | 3K |
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CODEXIS, INC. (CDXS) Snapshot price: $2.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.56% | 30.12K |
—
|
—
| 102.6K |
Jun 11
| |||
Form 4
| +91.35% | 34.6K |
—
|
—
| 72.48K |
Jun 13
| |||
Form 4
|
∞
| 37.88K |
—
|
—
| 37.88K |
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||